Domov › Okužbe s COVID-19 in koronavirusom › Georgia
Klinične študije za Okužbe s COVID-19 in koronavirusom v Georgia
6 študij za Okužbe s COVID-19 in koronavirusom išče udeležence na lokacijah v Georgia.
Mesta v Georgia
Uradno besedilo študije (angleško)
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
- The Hope Clinic of Emory University, Decatur
Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
Starost 18–64 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07536308A Study of COVID-19 Vaccine(s) in Children and Adults
- AGILE Clinical Research Trials, LLC, Atlanta
Vključevanje udeležencevFaza 3Vabljeni zdravi prostovoljci
Starost 5 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07798648A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Velocity Clinical Research, Savannah, Savannah
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07013474Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
- Emory University, Atlanta
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06631287A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- The Hope Clinic of Emory University, Decatur
- Javara - Privia Medical Group Georgia - Fayetteville, Fayetteville
- Coastal Heritage Clinical Research, Hinesville
- in še 1
Vključevanje udeležencevFaza 3
Starost 12 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06679140A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
- CenExel, Atlanta
- CenExel, Decatur
Vključevanje udeležencevFaza 4Vabljeni zdravi prostovoljci
6 Months · Vsi spoli · Posodobljeno 27. mar. 2026 · NCT06585241Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.